Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis
This study has been completed.
Study NCT01050777   Information provided by Tehran University of Medical Sciences

First Received on January 13, 2010.   Last Updated on June 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cutaneous Leishmaniasis
Additional conditions recognized in this trial
Leishmaniasis
Leishmaniasis, Cutaneous
More general conditions related to this trial
Euglenozoa Infections
Parasitic Diseases
Protozoan Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
Liposomal meglumine antimoniate
Liposomal Paromomycin
Placebo
Additional drug interventions recognized in this trial
Meglumine antimoniate
Paromomycin
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Tehran University of Medical Sciences
Mashhad University of Medical Sciences
Center for Research and Training in Skin Diseases and Leprosy


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services